StockData

Anterix vs SurgePays

ATEX and SURG side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ATEX and SURG compare

Anterix is the larger company, worth 213 times as much as SurgePays ($1.5B against $7.2M).

Anterix keeps more of each dollar of sales as profit, with a net margin of 933% compared with −47.9% at SurgePays.

Anterix scores higher on the StockData Score (12 against 1 for SurgePays), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricATEXSURG
Size and price
Market cap$1.5B$7.2M
Share price$78.86$0.137
Change, 1 year248%−93.2%
Change, 5 years31.3%−94.3%
Beta (5Y)0.932.51
Employees6430
StockData Score
Total score12 (better)1
Valuation score01 (better)
Growth score2 (better)0
Performance score4 (better)0
Health score6 (better)0
Dividend score00
Valuation
P/E22.5×–
P/S220×0.1× (better)
P/B5.4×–
EV/EBITDA20.0×–
P/FCF145×–
FCF yield0.69%–
Fair value$43.69–
Margin of safety−80.5%–
Growth
Revenue growth (TTM)18.9%–
Revenue growth, 5Y average47.8% (better)0.92%
Net income growth (TTM)124%–
EPS growth (TTM)123%–
Profitability
Gross margin–−19.6%
Operating margin1011% (better)−41.0%
Net margin933% (better)−47.9%
FCF margin151%–
Return on equity27.9%–
Return on invested capital40.7%–
Financial health
Debt / equity0.00–
Interest coverage–−15.3×
Current ratio4.85 (better)0.19
Altman Z-score4.30 (better)−21.51
Piotroski F-score6 (better)3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions97.4%4.4%
Held by insiders39.3%9.2%
Insider net buying, 12 months−$36.0M$83.0K (better)
Short interest, % of float14.0%9.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.